Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFOX-4 vs FOLFOX-4 plus cetuximab in resected stage III colon cancer
2005-003463-23Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Feb 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of cetuximab in colon cancer (2 arms), sponsored by Fédération Francophone de Cancérologie Digestive. Primary endpoint: Disease-free survival. Started Feb 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2005-003463-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003463-23.